← Back to Search

N/A

Person-Centered Care for Improving Quality of Life

N/A
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intended to receive radiation therapy to the breast/chest-wall and regional lymph nodes
Diagnosis of non-metastatic breast cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 weeks.
Awards & highlights

Study Summary

This trial is designed to study whether a person-centered model of care, which includes an additional educational session with a radiation therapist, can improve patient outcomes compared to the standard model of care.

Who is the study for?
This trial is for adults over 18 with non-metastatic breast cancer who speak English and can consent to treatment. They should be set to receive radiation therapy but haven't started any specific procedures or received previous radiation.Check my eligibility
What is being tested?
The study compares a person-centered model of care, which includes an extra education session, against the standard care during radiation therapy. Participants will answer quality of life questionnaires at different stages.See study design
What are the potential side effects?
Since this trial focuses on models of care and uses questionnaires without medical interventions, there are no direct side effects from drugs or treatments being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am planning to undergo radiation therapy for my breast cancer.
Select...
My breast cancer has not spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Anxiety Levels
Secondary outcome measures
Patient-reported engagement level
Patient-reported experience
Patient-reported preparedness for radiation therapy
+1 more

Side effects data

From 2008 Phase 4 trial • 314 Patients • NCT00734097
5%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Esomeprazole 40mg, Daily

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard Model-of-CareExperimental Treatment1 Intervention
Patients randomized to the standard model of care will be treated as per standard of care.
Group II: Person-Centered Model-of-CareExperimental Treatment1 Intervention
Patients randomized to the person-centered model-of-care will have a 30 minute education session with a radiation therapist in addition to the standard of care, radiation therapy procedures.

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,381 Total Patients Enrolled
53 Trials studying Breast Cancer
29,445 Patients Enrolled for Breast Cancer

Media Library

Person-centered model-of-care (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT04507568 — N/A
Breast Cancer Research Study Groups: Person-Centered Model-of-Care, Standard Model-of-Care
Breast Cancer Clinical Trial 2023: Person-centered model-of-care Highlights & Side Effects. Trial Name: NCT04507568 — N/A
Person-centered model-of-care (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04507568 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies within this clinical trial for participants?

"This clinical study, which was initially published on August 13th 2020 and last modified in October 6th 2022, is no longer recruiting patients. Nevertheless, there are 1640 other trials searching for volunteers at this moment."

Answered by AI
~23 spots leftby Apr 2025